Office of the Director, National Institutes of Health; Notice of Meeting, 20655-20656 [2016-08096]

Download as PDF Federal Register / Vol. 81, No. 68 / Friday, April 8, 2016 / Notices mstockstill on DSK4VPTVN1PROD with NOTICES • Do the reconciliation-related measures serve as adequate proxies to assess the subsequent use of exchanged information? What alternative, nationallevel measures (e.g., clinical quality measures) should ONC consider for assessing this specific aspect of interoperability? • Can state Medicaid agencies share health care provider-level data with CMS similar to how Medicare currently collects and reports on these data in order to report on progress toward widespread health information exchange and use? If not, what are the barriers to doing so? What are some alternatives? • These proposed measures evaluate interoperability by examining the exchange and subsequent use of that information across encounters or transitions of care rather than across health care providers. Would it also be valuable to develop measures to evaluate progress related to interoperability across health care providers, even if this data source may only available for eligible professionals under the Medicare EHR Incentive Program? Identifying Other Data Sources to Measure Interoperability ONC acknowledges that other data sources might exist that could aid in the measurement of interoperability. For example, other potential data sources are Medicare Fee-For-Service (FFS) claims data as well as performance data from other programs. Section 1848(q)(2)(B) of the Social Security Act, as added by section 101(c) of the MACRA, describes the measures and activities for each of the four performance categories under the MeritBased Incentive Payment System (MIPS), which includes meaningful use of certified EHR technology. These measures may also serve as a potential data source for assessing progress related to interoperability for MIPS eligible professionals. As the MIPS Program is implemented, ONC will be assessing whether any measures could be used for this purpose. Additionally, some of the information used to evaluate the performance of eligible professionals who participate in the alternative payment models (APMs) may also help inform progress related to interoperability. Additionally, ONC is considering use of electronically-generated data from certified EHR technology or other systems, such as log-audit data, or leveraging surveys of entities that enable exchange to evaluate progress related to widespread electronic information exchange and use. ONC recognizes this VerDate Sep<11>2014 17:48 Apr 07, 2016 Jkt 238001 will require collaboration and coordination with federal entities and stakeholders across the ecosystem including entities that enable exchange and interoperable health information use, such as technology developers, Health Information Organizations (HIOs) and Health Information Service Providers (HISPs). Overarching Questions • Should ONC select measures from a single data source for consistency, or should ONC leverage a variety of data sources? If the latter, would a combination of measures from CMS EHR Incentive Programs and national survey data of hospitals and physicians be appropriate? • What, if any, other measures should ONC consider that are based upon the data sources that have been described in this RFI? • Are there Medicare claims based measures that have the potential to add unique information that is not available from the combination of the CMS EHR Incentive Programs data and survey data? • If ONC seeks to limit the number of measures selected, which are the highest priority measures to include? • What, if any, other national-level data sources should ONC consider? Do technology developers, HISPs, HIOs and other entities that enable exchange have suggestions for national-level data sources that can be leveraged to evaluate interoperability for purposes of section 106(b)(1) of the MACRA (keeping in mind the December 31, 2018 deadline) or for interoperability measurement more broadly? • How should ONC define ‘‘widespread’’ in quantifiable terms across these measures? Would this be a simple majority, over 50%, or should the threshold be set higher across these measures to be considered ‘‘widespread’’? III. Collection of Information Requirements This document does not impose information collection requirements, that is, reporting, recordkeeping or third-party disclosure requirements. Consequently, there is no need for review by the Office of Management and Budget under the authority of the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.). IV. Response to Comments ONC typically receives a large public response to its published Federal Register documents. ONC will consider all comments received by the date and time specified in the ‘‘DATES’’ section PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 20655 of this document, but will not be able to acknowledge or respond individually to public comments. Dated: April 1, 2016. Karen DeSalvo, National Coordinator, Office of the National Coordinator for Health Information Technology. [FR Doc. 2016–08134 Filed 4–7–16; 8:45 am] BILLING CODE 4150–45–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the Council of Councils. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting Web site (https:// videocast.nih.gov). A portion of the meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4), and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Council of Councils. Open: May 20, 2016. Time: 8:15 a.m. to 11:15 a.m. Agenda: Call to Order and Introductions; Announcements; NIH Update; Undiagnosed Disease Network; Introduction to Zika Virus; Nonhuman Primate Models in Zika Virus; Introduction of and Updates from NHGRI. Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892. Closed: May 20, 2016. Time: 11:45 a.m. to 2:00 p.m. Agenda: Review of grant applications. Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892. E:\FR\FM\08APN1.SGM 08APN1 20656 Federal Register / Vol. 81, No. 68 / Friday, April 8, 2016 / Notices Open: May 20, 2016. Time: 2:00 p.m. to 4:10 p.m. Agenda: Update on Awards for the NIH Precision Medicine Initiative Cohort Program; Council Input in the Office of Behavioral and Social Sciences Research Strategic Plan; Update on Common Fund Program; and Closing Remarks. Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892. Contact Person: Franziska Grieder, DVM, Ph.D., Executive Secretary, Director, Office of Research Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, NIH, 6701 Democracy Boulevard, Room 948, Bethesda, MD 20892, GriederF@mail.nih.gov, 301–435–0744. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Council of Council’s home page at https:// dpcpsi.nih.gov/council/ where an agenda will be posted before the meeting date. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: April 5, 2016. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–08096 Filed 4–7–16; 8:45 am] BILLING CODE 4140–01–P mstockstill on DSK4VPTVN1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director; Notice of Charter Renewal In accordance with Title 41 of the U.S. Code of Federal Regulations, Section 102–3.65(a), notice is hereby given that the Charter for the National VerDate Sep<11>2014 17:48 Apr 07, 2016 Jkt 238001 Science Advisory Board for Biosecurity was renewed for an additional two-year period on April 7, 2016. It is determined that the National Science Advisory Board for Biosecurity is in the public interest in connection with the performance of duties imposed on the National Institutes of Health by law, and that these duties can best be performed through the advice and counsel of this group. Inquiries may be directed to Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy, Office of the Director, National Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, Maryland 20892 (Mail code 4875), Telephone (301) 496– 2123, or spaethj@od.nih.gov. Dated: April 4, 2016. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2016–08034 Filed 4–7–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Library of Medicine; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the meetings. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Library of Medicine Special Emphasis Panel; Scholarly Works G13. Date: July 8, 2016. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Library of Medicine, 6705 Rockledge Drive, Suite 301, Bethesda, MD 20817. Contact Person: Zoe E. Huang, MD, Scientific Review Officer, Extramural Programs, National Library of Medicine, NIH, 6705 Rockledge Drive, Suite 301, Bethesda, MD 20892–7968, 301–594–4937, huangz@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.879, Medical Library PO 00000 Frm 00051 Fmt 4703 Sfmt 9990 Assistance, National Institutes of Health, HHS) Dated: April 4, 2016. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2016–08033 Filed 4–7–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Dental & Craniofacial Research; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; NIDCR Zika Application Review. Date: May 5, 2016. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Guo He Zhang, Mph, Ph.D., Scientific Review Officer, Scientific Review Branch, Natl Institute of Dental and Craniofacial Research, National Institutes of Health, 6701 Democracy Boulevard Suite 672, Bethesda, MD 20892, zhanggu@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS) Dated: April 5, 2016. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–08101 Filed 4–7–16; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\08APN1.SGM 08APN1

Agencies

[Federal Register Volume 81, Number 68 (Friday, April 8, 2016)]
[Notices]
[Pages 20655-20656]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-08096]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the Council of Councils.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting. The open session will be 
videocast and can be accessed from the NIH Videocasting and Podcasting 
Web site (https://videocast.nih.gov).
    A portion of the meeting will be closed to the public in accordance 
with the provisions set forth in sections 552b(c)(4), and 552b(c)(6), 
Title 5 U.S.C., as amended. The grant applications and the discussions 
could disclose confidential trade secrets or commercial property such 
as patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Council of Councils.
    Open: May 20, 2016.
    Time: 8:15 a.m. to 11:15 a.m.
    Agenda: Call to Order and Introductions; Announcements; NIH 
Update; Undiagnosed Disease Network; Introduction to Zika Virus; 
Nonhuman Primate Models in Zika Virus; Introduction of and Updates 
from NHGRI.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 
20892.

    Closed: May 20, 2016.
    Time: 11:45 a.m. to 2:00 p.m.
    Agenda: Review of grant applications.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 
20892.


[[Page 20656]]


    Open: May 20, 2016.
    Time: 2:00 p.m. to 4:10 p.m.
    Agenda: Update on Awards for the NIH Precision Medicine 
Initiative Cohort Program; Council Input in the Office of Behavioral 
and Social Sciences Research Strategic Plan; Update on Common Fund 
Program; and Closing Remarks.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 
20892.
    Contact Person: Franziska Grieder, DVM, Ph.D., Executive 
Secretary, Director, Office of Research Infrastructure Programs, 
Division of Program Coordination, Planning, and Strategic 
Initiatives, Office of the Director, NIH, 6701 Democracy Boulevard, 
Room 948, Bethesda, MD 20892, GriederF@mail.nih.gov, 301-435-0744.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Council of Council's home 
page at https://dpcpsi.nih.gov/council/ where an agenda will be 
posted before the meeting date.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: April 5, 2016.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-08096 Filed 4-7-16; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.